View all our research

Investigating whether urine self-testing kits and community early detection clinics are an effective way of screening for bladder health problems including bladder cancer.

A randomised placebo-controlled phase III trial of the effect of the omega-3 fatty acid eicosapentaenoic acid (EPA) on colorectal cancer recurrence and survival…

Asking individuals affected by cancer to report their symptoms and concerns, and how these change over time, is important in helping to improve their wellbeing and…

Not only does Hull have the highest number of smokers, it also has the highest number of lung cancer deaths in Yorkshire.

Significant Event Audit (SEA) is a method that GPs and primary care teams use to try and improve the quality of care that they provide.

The lockdown and NHS reshuffle needed to deal with the COVID-19 pandemic had a big impact on cancer care.

An exploration of context-specific treatment pathways and experiences to inform intervention development for person-centred care

Bladder cancer is a common disease with worse outcomes in Yorkshire than the rest of the UK. 
This research programme will develop a tool to assess patient reported…

Recent advances in radiotherapy have resulted in an increased number of patients that can be cured of lung cancer. Increasingly, patients are surviving their lung…

This is a new Yorkshire Cancer Research funded study at the University of Sheffield and Sheffield Teaching Hospitals which will assess when novel medical images are…

Currently, follow-up care for breast cancer involves patients managing symptoms themselves and contacting professionals if needed. For bowel cancer, follow-up…

For many reasons (e.g. side effects, treatment beliefs), women with breast cancer struggle to adhere to adjuvant (post-treatment) hormonal therapy (HT). This is…